Lidco Share Discussion Threads

[buywell3] 12/3/2020 00:30

POST REMOVED

[maxk] 12/3/2020 00:21

buywell3 .. barking!

[buywell3] 12/3/2020 00:11

POST REMOVED

[buywell3] 10/3/2020 23:55

POST REMOVED

[buywell3] 10/3/2020 00:05

POST REMOVED

[7767] 09/3/2020 09:49

This hopefully means more HUP sign ups for future income and
There could be more demand from other countries including our own NHS

[multibagger] 09/3/2020 07:03

Wish all affected by Corona Virus a full recovery....LID playing a role.

RNS Number : 3551F

LiDCO Group Plc

09 March 2020
LiDCO Group Plc
("LiDCO" or the "Company")

Increased sales demand from China in response to COVID-19

LiDCO (AIM: LID), a leading supplier of hemodynamic monitoring company, announces that its Chinese distribution partner, Beijing Gloryway Medical Company, has recently sold a small number of monitors in Wuhan, China as a direct response to the COVID-19 virus outbreak.

A number of LiDCOrapid monitors had already been installed in the city prior to the COVID-19 outbreak. The recent purchase is to provide additional Intensive Care monitoring capabilities in order to treat the most acute cases of the infection. The transaction was able to be arranged without LiDCO or our distributors’ staff visiting Wuhan.

LiDCO has fully assessed the impact of the outbreak on its supply chain and is satisfied that its inventory levels and forward purchases of monitors would support a certain amount of above forecast demand should it arise in areas affected by Covid-19. The Company is in communication with healthcare institutions in a number of the affected areas and is prepared to be flexible in its approach in order to meet any short-term increased monitoring needs.

Commenting, Matt Sassone, Chief Executive Officer of LiDCO, said: “The proportion of patients who are admitted to Intensive Care following COVID-19 infection remains low, however, there is significant clinical evidence that the use of advanced hemodynamic monitoring for patients in intensive care is clinically beneficial. Whilst the Board doesn’t anticipate changing expectations at this time, the Company is prepared to support customers should they face an increased demand for intensive care.”

[buywell3] 17/2/2020 00:56

POST REMOVED

[ayl30] 14/2/2020 18:03

Hope so, would help liquidity as well. Good week ending on a 12mth high. Onwards and upwards

[multibagger] 14/2/2020 17:04

List of trades in LID available from this (ADVFN) website.

Last 2 reported sales on NEX were at 5.64p.

Looks like someone/fund is building a position - speculation on my part.

[multibagger] 14/2/2020 13:58

Bid has moved up on 2 trades. Let's hope it is a big buy being worked in the background.

[t0pgrader] 14/2/2020 13:46

FinnCap maintain their current year price target of 11p (3 x FY sales)

Also looks to me (and the CEO according to his recent presentation) like a takeover candidate for one of the much bigger US companies. If so, the exit multiple should be nearer 7 x sales

[buywell3] 14/2/2020 00:44

POST REMOVED

[t0pgrader] 13/2/2020 12:36

Same investor group. Details included in the RNS.

[multibagger] 13/2/2020 12:21

Liquidity very tight it appears ? And RNS re Eiffel Investment on board at over 10% stake.

Have to check if they were previously called Alto Invest who were big holders in LID.

[multibagger] 13/2/2020 09:09

Welcome TrentEndBoy :)

LID appears to be shaping up well though I think that we may need to demonstrate more revenue traction in the US for the market to take greater notice. Good to see +0.4p added to the share price so far. LID is quite tightly held so any major commercial news, this could move upwards pretty sharpish.

[trentendboy] 13/2/2020 08:53

Some nice results out from LID - interesting US and China developments. Only just found the new board. Potentially interesting times ahead.

[t0pgrader] 13/2/2020 07:55

I don't see an obvious issue with the positive cf in H2 and the £0.4m inaugural sales in China are a promising start but am surprised by US H2 revenues that are static vs H1.

[gbenson1] 13/2/2020 07:20

Progress appears to be ok, however cash on balance sheet down a whopping 17%, something just doesn't add up, am I missing something? Are the BOD salaries out of kilter?

[multibagger] 12/2/2020 16:21

Presentation from Growth and Innovation Forum 2020 at London:

[ayl30] 12/2/2020 14:48

Agree, dont think it was a disposalYes China and US mentioned as areas for growthGood succinct presentation, reaffirmed analyst estimates, debt free, has enough cash

[t0pgrader] 12/2/2020 11:53

I dont think today's RNS does indicate a sale - the holding is 7.01%